Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Editas Medicine: Business Highlights and Financial Results Reported

May 5, 2021 0

Editas Medicine Reporting Editas Medicine (EDIT) reported business highlights and financial results for the first quarter …

Vir Biotechnology

May 4, 2021 0

Prohost Portfolio PLUS #5 Vir Biotechnology Vir Biotechnology (VIR) combines cutting-edge technologies with immunologic insights to …

Gilead Sciences Conference Call Information. See Also: Compugen Announcements

April 29, 2021 0

Gilead Sciences First-Quarter 2021 Financial Results Conference Call Info Gilead Sciences (GILD) management will host a …

AstraZeneca: Tagrisso Recommended for Marketing Authorization in the EU for Early Stage EGFRm NSCLC

April 27, 2021 0

AstraZeneca: Tagrisso for Adult Patients with Early-Stage EGFRm NSCLC... AstraZeneca (AZN): Tagrisso (osimertinib) has been recommended …

Sanofi and AstraZeneca: Nirsevimab Protects Healthy Pre-Term and Term Infants from Respiratory Syncytial Virus

April 27, 2021 0

Sanofi and AstraZeneca MELODY Trial Results for Nirsevimab In March 2017, Sanofi (SNY) and AstraZeneca (

Vertex and CRISPR Therapeutics: The EMA Granted PRIME Designation to CTX001. Read Also: Cassava Sciences Encouraging News

April 26, 2021 0

Vertex and CRISPR Granted PRIME Designation from the EMA for CTX001 Vertex Pharmaceuticals (VRTX) and CRISPR Therapeutics …

Celldex Therapeutics See Also: More of Your Questions Answered

April 26, 2021 0

Prohost Portfolio PLUS #4 Celldex Therapeutics Celldex Therapeutics (CLDX) stock is gaining momentum. On April 12, …

Gilead and Eisai Submitted an Application to Japan’s PMDA for Approval of Filgotinib for UC

April 23, 2021 0

Gilead Sciences and Eisai Pharmaceutical Co Submitted an Application to Japan's PMDA for Filgotinib Galapagos NV …

Bristol-Myers Squibb: CHMP of the EMA Recommended Additional Approval of Onureg® as Maintenance Therapy for AML

April 23, 2021 0

European Authorities Recommended Additional Approval of Bristol-Myers Squibb Product Onureg® for AML Bristol-Myers Squibb (BMY): The …

Humanigen Inc Product Lenzilumab Combination with CAR T in DLBCL Protects from Severe Cytokine Syndrome

April 21, 2021 0

Humanigen Product Lenzilumab Combination with CAR-T At the recommended Phase 2 dose, lenzilumab in combination with …

Cassava Sciences Guidance for Simufilam. See Also: Its First Quarter 2021 Financial Results

April 21, 2021 0

Cassava Sciences Guidance and Financial Results Cassava Sciences (SAVA) announced financial results for the first quarter …

Vir Biotechnology and GlaxoSmithKline: The European Medicines Agency Started a Review of VIR-7831 for COVID-19

April 20, 2021 0

Vir Biotechnology and GlaxoSmithKline in April 2020 In April 2020, Vir Biotechnology and GlaxoSmithKline entered into …

Amylyx Pharmaceuticals: Continuing to Offer Promising Results in Treating ALS

April 20, 2021 0

Amylyx Pharmaceuticals Updated Plans to Advance AMX0035 Amylyx Pharmaceuticals, Inc. provided an update on its plans …

CureVac N.V.

April 18, 2021 0

Prohost Portfolio PLUS #3 CureVac N.V. We were looking forward to learning more important details about …

Inovio DNA Vaccine Candidate INO-4800 has Promising Results. Read Also: Sutro Biopharma Good News

April 15, 2021 0

Inovio Pharmaceuticals Promising Results for INO-4800 for COVID-19 Inovio Pharmaceuticals (INO) announces promising results of a …

Gilead Sciences: Another Accelerated Cancer Approval from the FDA

April 14, 2021 0

FDA Grants Accelerated Approval for Gilead Sciences Trodelvy® The United States Food and Drug Administration (FDA) …

The FDA Granted Breakthrough Therapy Designation to vTv Therapeutics for Type 1 Diabetes Product TTP399

April 13, 2021 0

vTv Therapeutics Receives Breakthrough Therapy Designation for TTP399 vTv Therapeutics (VTVT) - a clinical-stage biopharmaceutical company …

Re-Working Some Evaluated Biotechnology Firms

April 11, 2021 0

Prohost Portfolio PLUS #2 Re-Working Some Evaluated Biotechnology Firms Exelixis: 2020 and 2021 Wondering why Exelixis’ …

Gilead Sciences: FDA Fully Approves Trodelvy for Metastatic TNBC

April 8, 2021 0

Gilead Sciences is Granted FDA Approval for Trodelvy® Gilead Sciences (GILD), a company that has been …

Exelixis Latest News. See Also: TransMedics Group May Improve on Heart Transplants

April 7, 2021 0

Exelixis Latest News The latest news announced by Exelixis (EXEL) is the FDA acceptance of its …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd